title: Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia.
authors.forename: H Graf
authors.initials: HG
authors.lastname: Einsiedel
authors.forename: L
authors.initials: L
authors.lastname: Kawan
authors.forename: C
authors.initials: C
authors.lastname: Eckert
authors.forename: O
authors.initials: O
authors.lastname: Witt
authors.forename: I
authors.initials: I
authors.lastname: Fichtner
authors.forename: G
authors.initials: G
authors.lastname: Henze
authors.forename: K
authors.initials: K
authors.lastname: Seeger
mesh_terms: D000631:Aminopyridines / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids / Q000627:therapeutic use; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D009368:Neoplasm Transplantation; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D014183:Transplantation, Heterologous
chemical_list: D000631:Aminopyridines; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; C428024:pyroxamide